NCT06472492 Cognitive Enhancement in Unipolar Depression With Yoga
| NCT ID | NCT06472492 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Unipolar Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-05-17 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2024-05-17 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is evident from recent studies that cognitive deficits persist even after remission of depressive episode. Hence, in this study, the investigators would like to see whether specific Yoga practice will help in enhancing cognitive abilities in this population.
Eligibility Criteria
Inclusion Criteria: * Age more than 18years and less than 60 years * H/o at least one depressive episode which is under remission and at the time of examination and throughout the study duration, * Informed Consent Exclusion Criteria: * Comorbid Psychosis, OCD, Bipolar disorder * Comorbid ADHD, IDD * Comorbid substance dependence (except tobacco) * Comorbid major or minor cognitive impairment, * Bi temporal ECT within 6 months * Past yoga practice - regularly for 1 month within 3 months Pregnancy
Contact & Investigator
Vishwajit L Nimgaonkar, MD, PhD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT06472492 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Unipolar Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06472492 currently recruiting?
Yes, NCT06472492 is actively recruiting participants. Contact the research team at vishwajitnl@upmc.edu for enrollment information.
Where is the NCT06472492 trial being conducted?
This trial is being conducted at Bengaluru, India.
Who is sponsoring the NCT06472492 clinical trial?
NCT06472492 is sponsored by University of Pittsburgh. The principal investigator is Vishwajit L Nimgaonkar, MD, PhD at University of Pittsburgh. The trial plans to enroll 32 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.